DaVita Inc.

Equities

DVA

US23918K1088

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 16:00:02 2024-06-25 EDT			5-day change	1st Jan Change
142.9 ^USD	-0.67%		+0.50%	+36.43%

06-06	Nuwellis Extends Pilot Program With Dialysis Services Provider DaVita	MT
05-24	FMC, Fresenius and Davita rise after Ozempic news	DP

DaVita HealthCare Partners Inc. Announces Partnership with Fresenius Medical Care

January 08, 2013 at 01:30 pm

DaVita HealthCare Partners Inc. announced an agreement to provide certain pharmacy services to Fresenius Medical Care. FMC's contract with DaVita Rx will help implement that requirement by using DaVita Rx's pharmacy to fill and ship oral medications to FMC Medicare patients. DaVita Rx service for FMC will begin in late 2013.

Latest news about DaVita Inc.

Nuwellis Extends Pilot Program With Dialysis Services Provider DaVita	06-06	MT
FMC, Fresenius and Davita rise after Ozempic news	05-24	DP
Truist Securities Raises Price Target on DaVita to $150 From $135, Keeps Hold Rating	05-15	MT
Transcript : DaVita Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 05:01 PM	05-14
Davita Insider Sold Shares Worth $698,214, According to a Recent SEC Filing	05-14	MT
DaVita Appoints Madhu Narasimhan as Chief Information Officer, Effective June 3, 2024	05-13	CI
TD Cowen Adjusts Price Target on DaVita to $139 From $136	05-07	MT
UBS Adjusts Price Target on DaVita to $169 From $145, Maintains Buy Rating	05-03	MT
Deutsche Bank Adjusts Price Target on DaVita to $145 From $135	05-03	MT
Barclays Adjusts Price Target on DaVita to $150 From $133	05-03	MT
DaVita gains after upbeat quarterly profit prompts annual forecast raise	05-02	RE
DaVita Q1 Adjusted Earnings, Revenue Rise; 2024 EPS Guidance Range Narrows; Shares Gain After Hours	05-02	MT
Transcript : DaVita Inc., Q1 2024 Earnings Call, May 02, 2024	05-02
Earnings Flash (DVA) DAVITA Reports Q1 EPS $2.38, vs. Street Est of $1.89	05-02	MT
Earnings Flash (DVA) DAVITA Reports Q1 Revenue $3.07B, vs. Street Est of $3.02B	05-02	MT
Tranche Update on DaVita Inc.'s Equity Buyback Plan announced on December 10, 2020.	05-02	CI
DaVita Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
DaVita Inc. announces an Equity Buyback.	05-01	CI
DaVita Inc. authorizes a Buyback Plan.	04-29	CI
DaVita Inc. Announces Designing and Opening the First All-Electric Net-Zero Dialysis Center in the U.S, Powered by Solar Energy	04-22	CI
Davita Announces Dennis Pullin to Its Board of Directors	04-10	CI
DaVita Inc. completed the acquisition of Dialysis clinic networks in Chile from Fresenius Medical Care AG.	03-30	CI
Transcript : DaVita Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:00 AM	03-13
Deutsche Bank Adjusts DaVita Price Target to $135 From $120, Maintains Hold Rating	03-08	MT
Sector Update: Health Care Stocks Retreating Late Afternoon	03-05	MT

Chart DaVita Inc.

Duration

Period

More charts

Company Profile

DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows: - supply of dialysis services (95.3%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2023, services are insured through 2,675 dialysis centers serving nearly 200,800 patients in the United States, and through 367 dialysis centers serving nearly 49,400 patients abroad; - other (4.7%).

Sector

Healthcare Facilities & Services

Calendar

2024-07-31 - Q2 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for DaVita Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

142.9 USD

Average target price

142.2 USD

Spread / Average Target

-0.51%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
DAVITA INC.	+36.43%	12.53B
HCA HEALTHCARE, INC.	+25.78%	89.17B
CVS HEALTH CORPORATION	-23.45%	75.87B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.32%	27.41B
LABCORP HOLDINGS INC.	-8.56%	17.52B
FRESENIUS SE & CO. KGAA	+0.32%	17.04B
QUEST DIAGNOSTICS INCORPORATED	+0.30%	15.36B
NATERA, INC.	+77.76%	13.67B
TENET HEALTHCARE CORPORATION	+78.55%	13.18B
PURE HEALTH HOLDING	-25.61%	12.83B

Other Healthcare Facilities & Services